Fig. 2

a-b The migration abilities of indicate treated Aspc-1 (a) and Capan-1 cells (b) were measured by wound-healing assays. Scale bars = 50 μm. c-d The invasion abilities of indicate treated Aspc-1 (c) and Capan-1 cells (d) were measured by transwell assays. Scale bars = 50 μm. e-f The proliferation abilities of indicate treated Aspc-1 (e) and Capan-1 cells (f) were measured by EdU assays. Scale bars = 50 μm. g-h The proliferation abilities of indicate treated Aspc-1 (g) and Capan-1 cells (h) were measured by CCK-8 assays daily for 3 days. i-j The indicate treated Aspc-1 (i) and Capan-1cells (j) were stained by propidium iodide and analyzed using flow cytometry. k-l. The in vitro angiogenesis abilities of indicated treated Aspc-1 (k) and Capan-1 cells (l) were measured by tube-formation assays of HUVECS cells. Scale bars = 50 μm